Jürg Gertsch

Jürg Gertsch studied cultural anthropology at the Universidad Central de Venezuela (UCV) and Neurosciences and Biochemistry at Sussex University (UK) and the Biozentrum Basel. He received his M.Sc. in Biochemistry (1997) and his PhD in pharmacognosy, ethnobotany and natural product chemistry from the Swiss Federal Institute of Technology (ETH) Zurich in 2002. Between 2003 and 2009 he was postdoc and then group leader at the Institute of Pharmaceutical Sciences at ETH Zurich. He has carried out fieldwork in Venezuela, Sarawak, Mexico and Bolivia. Since 2013 he is full professor and deputy and co-director of the Institute of Biochemistry and Molecular Medicine. Dr. Gertsch’s research focuses on molecular pharmacology and analytics of the endocannabinoid system and drug discovery, cannabinoid pharmacology and translational research. His research group works on projects related to chemical biology, neuropharmacology and biochemical pharmacology of lipids, with a focus on translation. He has been coordinating different research grants related to the endocannabinoid system and medical cannabis. He is a co-founder of Synendos Therapeutics and Tasteomics.